OSAM
EVOK

O'Shaughnessy Asset Management’s Evoke Pharma EVOK Stock Holding History

O'Shaughnessy Asset Management’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4
Closed -$1K – 2607
2021
Q1 		$1K Hold
4
– – ﹤0.01% 2173
2020
Q4 		$1K Buy
+4
New +$2.06K ﹤0.01% 1922
2020
Q3 		– Hold
0
– – – 1904

Other funds holding EVOK

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

O'Shaughnessy Asset Management's EVOK Position: Q2 2021 in Review

O'Shaughnessy Asset Management sold out of Evoke Pharma (EVOK) in Q2 2021, closing a stake of 4 shares — an estimated $1K sold.

O'Shaughnessy Asset Management first reported a position in EVOK in Q4 2020 and held it in 2 quarters. The position peaked at $1K in Q1 2021. 19 funds tracked by Wall St. Rank hold EVOK as of Q2 2021.

  • O'Shaughnessy Asset Management reported no remaining Evoke Pharma position as of Q2 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 4 Evoke Pharma shares in Q2 2021, an estimated $1K.
  • O'Shaughnessy Asset Management first reported a position in Evoke Pharma in Q4 2020 and held it in 2 quarters.
  • O'Shaughnessy Asset Management's Evoke Pharma position peaked at $1K in Q1 2021.
  • 19 funds tracked by Wall St. Rank held Evoke Pharma as of Q2 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.